#buyrating
Revisiting: TransDigm: Commercial Exposure Drives Sell-Off, But Valuation Now Attractive #TransDigm #Investing #StockMarket #TDG #BuyRating
TransDigm: Commercial Exposure Drives Sell-Off, But Valuation Now Attractive (NYSE:TDG)
TransDigm shares have declined over 10%, but I maintain a buy rating with a $1,537 price target, implying 32% upside. Click here to read why TDG is a Buy.
dlvr.it
May 1, 2026 at 4:10 PM
Lithia Gets Citi Buy After April 13 Note: Citi reiterated a Buy on Lithia (LAD) on Apr 13, 2026 (Source: Yahoo Finance); institutional investors should assess used-vehicle margins and acquisition returns before revising… 👈 Read full analysis #Lithia #CitiGroup #BuyRating #Investing #StockMarket
Lithia Gets Citi Buy After April 13 Note
Citi reiterated a Buy on Lithia (LAD) on Apr 13, 2026 (Source: Yahoo Finance); institutional investors should assess used-vehicle margins and acquisition returns before revising allocations.
dlvr.it
April 13, 2026 at 10:58 AM
🏦 Coinbase earns Buy rating

Goldman Sachs assigned a Buy rating to Coinbase, highlighting the platform’s structural expansion and competitive positioning in the digital asset market.

#Coinbase #GoldmanSachs #BuyRating #Crypto
Coinbase Earns Buy Rating as Goldman Highlights Structural Expansion - Crypto Economy
Goldman Sachs upgraded Coinbase’s rating to “Buy,” anticipating strong growth in cryptocurrency integration with traditional finance.
crypto-economy.com
January 5, 2026 at 6:04 PM
www.newsmason.com
June 24, 2025 at 3:09 PM
Freshpet Shares Rise After TD Cowen Upgrade: TD Cowen upgraded Freshpet to Buy on Apr 8, 2026; shares rose about 5% that day as the firm cited improving sales momentum (Investing.com). 👈 Read full analysis #Freshpet #StockMarket #TD_Cowen #Investing #BuyRating
Freshpet Shares Rise After TD Cowen Upgrade
TD Cowen upgraded Freshpet to Buy on Apr 8, 2026; shares rose about 5% that day as the firm cited improving sales momentum (Investing.com).
dlvr.it
April 8, 2026 at 10:50 AM
Kura Sushi Maintained at Buy by DA Davidson Ahead of Q1: DA Davidson kept a Buy on Kura Sushi (KRUS) on Apr 6, 2026; the maintained rating stabilizes expectations ahead of Q1 earnings and points to no anticipated… 👈 Read full analysis #KuraSushi #BuyRating #Investing #StockMarket #EarningsReport
Kura Sushi Maintained at Buy by DA Davidson Ahead of Q1
DA Davidson kept a Buy on Kura Sushi (KRUS) on Apr 6, 2026; the maintained rating stabilizes expectations ahead of Q1 earnings and points to no anticipated material downside (Investing.com).
dlvr.it
April 6, 2026 at 3:38 PM
MP Materials Buy Rating Maintained by BofA at $94: BofA kept a Buy on MP Materials with a $94 target on Apr 1, 2026 (Investing.com); USGS 2024 data shows China produced ~85% of processed rare earths in 2023. 👈 Read full analysis #MPMaterials #BofA #BuyRating #RareEarths #Investing
MP Materials Buy Rating Maintained by BofA at $94
BofA kept a Buy on MP Materials with a $94 target on Apr 1, 2026 (Investing.com); USGS 2024 data shows China produced ~85% of processed rare earths in 2023.
dlvr.it
April 1, 2026 at 11:22 AM
Lithia Motors Buy Rating Reiterated; Q1 Estimate Cut: Benchmark reiterated Buy on Lithia on Mar 30, 2026 and trimmed Q1 estimates by ~3% (Investing.com, 13:55:14 GMT), raising sector-level questions about used-car… 👈 Read full analysis #LithiaMotors #StockMarket #Investing #BuyRating #MarketTrends
Lithia Motors Buy Rating Reiterated; Q1 Estimate Cut
Benchmark reiterated Buy on Lithia on Mar 30, 2026 and trimmed Q1 estimates by ~3% (Investing.com, 13:55:14 GMT), raising sector-level questions about used-car spreads and fixed-ops resilience.
dlvr.it
March 30, 2026 at 2:21 PM
Globe Life Rated Buy at $170 by Texas Capital: Texas Capital initiated Globe Life (GL) with a Buy rating and $170 price target on Mar 28, 2026 (Yahoo Finance); institutional investors should reconcile… 👈 Read full analysis #GlobeLife #TexasCapital #BuyRating #InvestmentStrategies #LifeInsurance
Globe Life Rated Buy at $170 by Texas Capital
Texas Capital initiated Globe Life (GL) with a Buy rating and $170 price target on Mar 28, 2026 (Yahoo Finance); institutional investors should reconcile models to this new research.
dlvr.it
March 29, 2026 at 10:27 AM
Ocular Therapeutix Rated Buy by H.C. Wainwright: H.C. Wainwright reiterated a Buy on Ocular Therapeutix on Mar 27, 2026 (11:37:29 GMT); institutional investors should verify company filings and upcoming… 👈 Read full analysis #OcularTherapeutix #Investing #FinancialNews #StockMarket #BuyRating
Ocular Therapeutix Rated Buy by H.C. Wainwright
H.C. Wainwright reiterated a Buy on Ocular Therapeutix on Mar 27, 2026 (11:37:29 GMT); institutional investors should verify company filings and upcoming catalysts.
dlvr.it
March 27, 2026 at 12:05 PM
PDD Holdings Upgraded to Buy by Nomura: Nomura upgraded PDD to Buy on Mar 27, 2026; Temu (launched Sep 2022) is central to the call and investors should reassess exposure as international monetization is tested. 👈 Read full analysis #PDDHoldings #Nomura #Investment #BuyRating #Temu
PDD Holdings Upgraded to Buy by Nomura
Nomura upgraded PDD to Buy on Mar 27, 2026; Temu (launched Sep 2022) is central to the call and investors should reassess exposure as international monetization is tested.
dlvr.it
March 27, 2026 at 5:49 AM
HC Wainwright reaffirms buy rating for Edesa Biotech (NASDAQ:EDSA), setting a $21 price target. 📈 #BuyRating #EdesaBiotech https://fefd.link/Yuh5e
May 7, 2025 at 8:40 PM
UBS initiates “buy” on Sixt SE, sees margins, U.S. market gains driving upside
Investing.com -- UBS has initiated coverage of Sixt SE (ETR:SIXG) with a “buy” rating, citing stronger cost efficiency, improved fleet management and realistic prospects for U.S. market share gains. Shares of the Pullach-headquartered company were up 4% at 04:24 ET (08:24 GMT). The German car rental company, which operates in Europe and North America, reported €4.0 billion in revenue in 2024. UBS projects sales to rise to €4.3 billion in 2025 and €5.5 billion by 2029, representing a 7% compound annual growth rate. Net earnings are forecast to grow from €244 million in 2024 to €325 million in 2025 and €515 million in 2029. Diluted earnings per share are expected to increase from €5.20 in 2024 to €6.93 in 2025 and €10.97 by 2029. UBS analysts said margin recovery is being driven by internal factors. “The margin recovery story is driven by fleet management, instead of the external pricing environment,” the note said. The brokerage expects EBT margins of 11-13% between 2025 and 2027, compared with company guidance of about 10% for 2025 and consensus of 10.2%. The EBIT margin is projected to rise from 12.1% in 2024 to 13.9% in 2025 and 15.7% in 2027. UBS estimates that rental depreciation tailwinds from a refreshed fleet will add 130-250 basis points to margins. Depreciation per unit per month fell below €300 in the second quarter, a trend analysts said supports long-term profitability. “We believe Sixt is now very well positioned to navigate residual value uncertainties regardless of the used car pricing environment,” they said. 3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads. Regional growth is expected to remain uneven. Revenues from Germany, which account for about 30% of the total, are forecast to grow 1-2% annually, while the rest of Europe, representing roughly 40%, is projected to grow 10% annually on strong inbound demand. In North America, which makes up about 30% of sales, revenue is forecast to expand at an 8% annual pace as market share rises from 3% to 5% by 2029. UBS noted that Sixt operates fewer than 10% of the stations of its larger U.S. rivals but generates revenue per station above €10 million annually. Dividend payouts are projected to recover alongside earnings. The dividend per share is expected to rise from €2.70 in 2024 to €3.81 in 2025 and €6.03 in 2029, with a consistent payout ratio of 55%. The dividend yield is forecast to climb from 3.5% in 2024 to 7.4% in 2029. Valuation metrics indicate upside potential. Shares closed at €81.05 on Sept. 3, giving the company a market capitalization of €3.40 billion. UBS set a 12-month price target of €102, saying the stock is trading at 13 times consensus 2025 earnings, at the low end of its historical range of 12x to 19x. The brokerage said, “a re-rating toward the historical average of 16x is likely as margin expansion materialises and gets recognised.” UBS flagged risks including macroeconomic conditions, geopolitical tensions, trade policies, residual value fluctuations and aggressive fleet expansion by competitors. 3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads.
www.investing.com
September 5, 2025 at 8:29 AM
Olaplex stock jumps after receiving first buy rating from Wall Street
Investing.com -- Olaplex Holdings (NASDAQ:OLPX) stock surged 12% Monday after receiving its first buy rating from Wall Street analysts, marking a potential turning point for the prestige beauty brand. Canaccord Genuity analyst Susan Anderson upgraded Olaplex from Hold to Buy and raised her price target to $2.00 from $1.50, representing a 43% upside from Friday’s closing price of $1.40. This makes Anderson the sole bullish voice among approximately nine firms covering the stock. In her upgrade note, Anderson cited a "brand reinvigoration" at Olaplex, suggesting the company is "ready to shine as a highly profitable prestige beauty brand set to return to growth." She highlighted the company’s journey since its IPO, which saw sales initially grow at triple-digit rates to over $700 million annualized before normalizing to its current $400+ million run rate. The analyst noted that after 2.5 years of normalization, Olaplex is finally seeing sales and margins stabilize. The company reported sales growth in the second quarter and could potentially return to positive annual growth in fiscal year 2025. Meanwhile, adjusted EBITDA margins are settling at industry-standard low-20% rates, down from previous levels exceeding 60%. Olaplex’s stock movement reflects growing confidence that investments in marketing, merchandising, and innovation are beginning to yield results for the hair care brand. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C. 3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads. ProPicks AI analyzes thousands of stocks using 100+ institutional-grade financial metrics to identify the strongest opportunities. With 80+ strategies across global markets, you might be surprised where OLPX appears. Our flagship Tech Titans strategy doubled the S&P 500 within 18 months, including notable winners like Super Micro Computer (+185%) and AppLovin (+157%). Each strategy refreshes monthly with 10-20 high-conviction picks. Even if OLPX isn't currently featured, you'll discover similar opportunities in the same industry or theme—stocks the AI identifies before they breakout. Now up to 50% off while our Summer Sale lasts.
www.investing.com
August 25, 2025 at 6:49 PM
www.investing.com
August 22, 2025 at 1:54 PM
Why Stifel says buy this quantum computing stock
Investing.com -- Stifel initiated coverage of D-Wave Quantum Inc. with a Buy rating and a $26 target price in a note this week, citing the company’s leadership in quantum annealing and growing commercial traction. “We view QBTS as a pioneering quantum computing company and the first to deliver commercial quantum annealing systems,” Stifel wrote. Founded in 1999, D-Wave has built a broad customer base and achieved a key milestone earlier this year by selling its first quantum annealing system to the Julich Supercomputing Centre in Germany. Stifel sees this as an indication of strong commercial viability. Following a recent equity raise, D-Wave exited the first quarter of 2025 with $304 million in cash. According to Stifel, management has indicated that “the company is funded sufficiently to reach profitability.” Looking ahead, Stifel is optimistic about industry growth. “Using various industry forecasts, we believe that the quantum computing market is on track to grow into a $10 billion market by 2030,” the analysts wrote. With a base case assumption of 15% market share for D-Wave, they derive a $26 price target based on a 5x price-to-sales multiple on longer-term revenue assumptions. Stifel’s bullish stance is underpinned by D-Wave’s commercial momentum, strong cash position, and differentiated technology. The firm believes the company is well-positioned to capture a significant portion of what it views as a rapidly expanding market. Don't miss out on the next big opportunity! Stay ahead of the curve with ProPicks – 6 model portfolios fueled by AI stock picks with a stellar performance this year.. In 2024 alone, ProPicks' AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. That's an impressive track record. With portfolios tailored for Dow stocks, S&P stocks, Tech Stocks, and Mid Cap stocks, you can explore various wealth-building strategies. So if QBTS is on your watchlist, it could be very wise to know whether or not it made the ProPicks lists.
www.investing.com
August 5, 2025 at 6:14 PM
Citi initiates Celsius at Buy on category growth, global expansion potential
Investing.com -- Citi initiated coverage of Celsius Holdings (NASDAQ:CELH) with a Buy rating and a $55 price target given strong near-term momentum in the U.S. energy drink market and long-term international growth opportunities. Citi expects Celsius to benefit from accelerating sales in 2025, helped by both its core Celsius brand and the recently acquired Alani Nu, which is expanding distribution and product innovation. The firm projects second-quarter sales growth of 66.4%, ahead of the 60.7% consensus, and full-year 2025 growth of 63.8%. In the longer term, Citi sees room for substantial distribution gains. The company’s total distribution points (TDPs) remain significantly below those of Monster and Red Bull, offering room for domestic share gains. Internationally, Celsius derives just 5% of its revenue from outside the U.S., compared with roughly 40% for Monster, suggesting meaningful white space. Citi forecasts 12% annual topline growth through 2030, including 25% growth internationally, and sees 25% annual EPS growth over the same period, supported in part by cost synergies from the Alani Nu deal. While acknowledging concerns around valuation, Celsius trades at about 36 times 2026 earnings—Citi argues the stock looks more reasonable on a growth-adjusted basis, with a PEG ratio of 1.2 versus peer averages near 2.6. Risks noted include potential volatility between scanner data and reported results, innovation-driven growth that may be harder to sustain, overlap between the Celsius and Alani brands, and already-positive investor sentiment. Still, Citi believes distribution expansion and brand differentiation can offset those concerns.
www.investing.com
July 23, 2025 at 2:46 PM
Deutsche Bank starts Cinemark at Buy as it sees box office recovery driving cash
Investing.com -- Deutsche Bank initiated coverage of Cinemark with a Buy rating and a $36 price target, citing an expanding film slate and industry normalization that should support a sustained box office recovery and stronger free cash flow. The firm sees roughly 25% upside from current levels and views Cinemark as well-positioned due to its U.S. and Latin American footprint and modern theater circuit. While the sector’s recovery from the pandemic had been progressing, the Hollywood strikes disrupted momentum through early 2025, particularly with fewer major studio releases. Deutsche Bank said second-quarter box office trends suggest a turning point, with results matching 2023 levels despite a lighter release calendar. The firm expects a fuller recovery to take hold in the second half of 2025 and into 2026 as studios ramp production and new distributors, including Amazon (NASDAQ:AMZN) MGM and A24, boost theatrical output. Amazon MGM alone is expected to add 14–16 theatrical releases per year by 2027, potentially restoring the number of wide releases to pre-pandemic levels. That increase, coupled with Cinemark’s operating leverage and market positioning, should drive double-digit free cash flow growth and stronger shareholder returns, according to the note. Cinemark shares have lagged the broader market in recent years but could benefit from a more stable industry backdrop and a larger, more consistent film pipeline, Deutsche Bank said.
www.investing.com
July 10, 2025 at 6:59 PM
BofA reinstates Estee Lauder with Buy, sees 30% upside as Asia headwinds ease
Investing.com -- Bank of America reinstated coverage of Estee Lauder (NYSE:EL) with a Buy rating and $110 price target, given signs of recovery in Asia and renewed confidence in the company’s restructuring plan. The target implies roughly a 30% upside. Estee Lauder, the world’s second-largest player in the $160 billion global prestige beauty market, has seen its earnings fall sharply in recent years, with EPS down 80% from its peak. Much of the drag has come from China and travel retail in Asia, which together account for a significant share of revenue. BofA said it believes the worst may be over. Demand in China has picked up in the past two quarters and discounting trends are becoming more rational, particularly during major shopping events. The firm expects further improvement in the current quarter and a return to growth in Hainan duty-free sales by fiscal 2026, though it remains cautious on Korea due to ongoing wholesale exits. The bank is backing the company’s “Beauty Reimagined” plan, which aims to revive sales and restore double-digit operating margins. BofA forecasts 4% annual revenue growth and 430 basis points of margin expansion by FY27, putting its earnings estimates about 10% above consensus. Key elements of the strategy include faster product launches, greater focus on high-growth retail channels, and a 10% workforce reduction aimed at generating up to $1 billion in gross savings. Management plans to reinvest those savings into brand and advertising spend. Estee Lauder currently trades at a steep discount to global beauty peers, and BofA believes improved execution and signs of market recovery could support a re-rating. Don't miss out on the next big opportunity! Stay ahead of the curve with ProPicks – 6 model portfolios fueled by AI stock picks with a stellar performance this year.. In 2024 alone, ProPicks' AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. That's an impressive track record. With portfolios tailored for Dow stocks, S&P stocks, Tech Stocks, and Mid Cap stocks, you can explore various wealth-building strategies. So if EL is on your watchlist, it could be very wise to know whether or not it made the ProPicks lists.
www.investing.com
July 10, 2025 at 5:06 PM